JPH03162829A - Conductive tacky adhesive agent for medical treatment - Google Patents

Conductive tacky adhesive agent for medical treatment

Info

Publication number
JPH03162829A
JPH03162829A JP2220450A JP22045090A JPH03162829A JP H03162829 A JPH03162829 A JP H03162829A JP 2220450 A JP2220450 A JP 2220450A JP 22045090 A JP22045090 A JP 22045090A JP H03162829 A JPH03162829 A JP H03162829A
Authority
JP
Japan
Prior art keywords
adhesive
meth
acrylic acid
weight
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2220450A
Other languages
Japanese (ja)
Other versions
JPH0783743B2 (en
Inventor
Kunio Yoneto
邦夫 米戸
Takeshi Inoue
健 井上
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP2220450A priority Critical patent/JPH0783743B2/en
Publication of JPH03162829A publication Critical patent/JPH03162829A/en
Publication of JPH0783743B2 publication Critical patent/JPH0783743B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

PURPOSE:To obtain the conductive tacky adhesive agent for medical treatments which has an excellent electrical conductivity, tacky adhesiveness, cohesive property, and moisture resistance and is less in stimulation to skin by incorporating the blended polymer of a vinylpyrrolidone (co)polymer and a (meth)acrylic acid (salt) - (meth)acrylic alkyl ester copolymer, an electrolyte and a softening agent into this adhesive agent. CONSTITUTION:The vinylpyrrolidone (co)polymer includes vinylpyrrolidone homopolymer, copolymers of 1 or >=2 kinds of vinylpyrrolidone and acrylic acid, methyl methacrylate, maleic anhydride, vinyl alcohol, etc. The (meth)acrylic acid (salt) is incorporated as a copolymer component at 5 to 90mol% into the (meth)acrylic acid (salt) - (meth)acrylic alkyl ester copolymer which is incorporated at 1 to 30wt.% into the blended polymer. Moisture resistance and internal cohesion power are enhanced if an org. carboxylic acid (salt) is added to this tacky adhesive agent. The electrolyte is adequately inorg. salts, such as NaCl, KCl and CaCl2. The softening agent is adequately high boiling water-soluble or hydrophilic liquids, such as polyhydric alcohol and polyhydric alcohol derivatives.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は導電性、粘着性、凝集性及び耐湿性に優れ、皮
膚刺激のない医療用導電性粘着剤に関する. (従来の技術) 心電図、筋電図、脳波計、低周波治療器、手術用電気メ
スなどの医療用電気機器を使用する場合には、生体に信
号用電極やアース用電極を接触させ、生体の所定の場所
とこれらの機器とを電気的に接続したり生体を接地する
ことが行われている.このような生体と電極との媒介体
として、様々な組戒の導電性粘着剤が提案されている。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a medical conductive adhesive that has excellent conductivity, adhesiveness, cohesion, and moisture resistance, and does not cause skin irritation. (Prior art) When using medical electrical equipment such as electrocardiograms, electromyograms, electroencephalograms, low-frequency treatment devices, and surgical electric scalpels, signal electrodes and grounding electrodes are brought into contact with the living body. These devices are electrically connected to predetermined locations, and living bodies are grounded. Various types of conductive adhesives have been proposed as mediators between such living bodies and electrodes.

例えば、 ■特開昭52−95895号公報に開示された導電性粘
着剤は、α,β−オレフィン性不飽和カルボン酸と末端
が第4級アンモニウム基であるl価もしくは多価アルコ
ールとのエステルを含むボリマーと多価アルコールを含
有する。
For example, ■The conductive adhesive disclosed in JP-A No. 52-95895 is an ester of an α,β-olefinically unsaturated carboxylic acid and a l-hydric or polyhydric alcohol whose terminal end is a quaternary ammonium group. Contains polymers and polyhydric alcohols.

■特開昭56−36939号公報に開示された導電性粘
着剤は、(メタ)アクリル酸、マレイン酸等の有機カル
ボン酸の塩(アルカリ金属塩、アミン塩など)を5モル
%以上の割合で含むボリマーと多価アルコールとを含有
する。
■The conductive adhesive disclosed in JP-A-56-36939 contains salts of organic carboxylic acids (alkali metal salts, amine salts, etc.) such as (meth)acrylic acid and maleic acid in a proportion of 5 mol% or more. Polyhydric alcohol and a polymer comprising:

■特開昭56−36940号公報に開示された導電性粘
着剤は、ポリアクリル酸、ポリビニルアルコール等の非
イオン性親水性ポリマーと、グリセリンなどの水溶性軟
化剤とを含有する。
(2) The conductive adhesive disclosed in JP-A-56-36940 contains a nonionic hydrophilic polymer such as polyacrylic acid or polyvinyl alcohol, and a water-soluble softener such as glycerin.

■特開昭63−92638号公報に開示された導電性粘
着剤は、(A)分子内に(無水)マレイン酸及び/又は
マレイン酸塩及び/又はマレイン酸部分エステルを有す
るボリマーと、(B)グリセリン等の多価アルコールと
、(C)エチレングリコールジグリシジルエーテル等の
多官能エボキシ化合物と、CD)NaC1等の低分子電
解質と、(E)NaOH、トリエタノールアミン等の中
和剤及び水を含有する。
■The conductive adhesive disclosed in JP-A No. 63-92638 consists of (A) a polymer having (anhydride) maleic acid and/or maleate salt and/or maleic acid partial ester in the molecule; ) polyhydric alcohol such as glycerin, (C) polyfunctional epoxy compound such as ethylene glycol diglycidyl ether, CD) low molecular electrolyte such as NaC1, (E) neutralizing agent such as NaOH, triethanolamine, and water. Contains.

しかし、上記4例を含め先行技術による導電性粘着剤は
、いずれも内部凝集力が不十分で、かつ粘着性が不十分
である。従って、生体と粘着剤とを強固に接着すること
ができず、かつ着脱の際に、粘着剤の残留分が残るとい
う欠点を有する。更に、いずれの導電性粘着剤も、耐湿
性に乏しく、例えば、高湿度下で使用すると、粘着性が
低下して短時間のうちに剥がれ落ちるか、あるいは粘着
剤の流動性が過剰になり電極と皮膚との間に接触不良を
起こすという欠点を有する。また、 特開昭63−92
683号公報に開示された導電性粘着剤のように粘着剤
中に水を含有させる必要がある場合、電極の使用中ある
いは保存中に水の蒸発により導電性及び粘着性の変化を
きたし、電気的な性能に影響を与えるという欠点を有す
ると共に、水の蒸発を防止するための特殊な包装を必要
とするため高価となる。
However, all of the conductive adhesives according to the prior art including the above four examples have insufficient internal cohesive force and insufficient adhesiveness. Therefore, it has the disadvantage that it is not possible to firmly adhere the adhesive to the living body, and that residual adhesive remains when the adhesive is attached or detached. Furthermore, all conductive adhesives have poor moisture resistance; for example, when used under high humidity, their adhesiveness decreases and they peel off in a short period of time, or the fluidity of the adhesive becomes excessive and the electrode It has the disadvantage of causing poor contact between the skin and the skin. Also, JP-A-63-92
When it is necessary to contain water in the adhesive, such as the conductive adhesive disclosed in Publication No. 683, the conductivity and adhesiveness change due to evaporation of water during use or storage of the electrode, causing electrical This has the disadvantage that it affects the performance of the water, and it is expensive because it requires special packaging to prevent water evaporation.

(発明が解決しようとする課題) 本発明は上記従来の欠点を解決するものであり、その目
的とするところは、各種医療用電気機器などに使用され
得、優れた導電性と粘着性及び耐湿性を有し、かつ皮膚
に対する刺激がなく、さらに安価に提供し得る導電性粘
着剤を提供することにある。
(Problems to be Solved by the Invention) The present invention solves the above-mentioned conventional drawbacks, and aims to provide a material with excellent conductivity, adhesiveness, and moisture resistance that can be used in various medical electrical equipment. It is an object of the present invention to provide a conductive adhesive that has good properties, does not irritate the skin, and can be provided at a low cost.

(課題を解決するための手段) 本発明の導電性粘着剤は、ビニルピロリドン(共)重合
体と(メタ)アクリル酸(塩)−(メタ)アクリル酸ア
ルキルエステル共重合体のブレンドポリマーと、電解質
及び軟化剤を主成分として含有し、そのことにより上記
の目的が達威される。
(Means for Solving the Problems) The conductive adhesive of the present invention comprises a blend polymer of a vinylpyrrolidone (co)polymer and a (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer, It contains an electrolyte and a softener as main components, thereby achieving the above purpose.

すなわち、ビニルピロリドン(共)重合体、電解質及び
軟化剤からなる粘着剤(粘着剤或分I)は皮膚への刺激
はなく、しかも導電性は良好であるが、耐湿性に劣り、
内部凝集力が弱く着脱の際支障をきたしており、医療用
導電性粘着剤としては好ましくない。この粘着剤成分I
に(メタ)アクリル酸(塩)−(メタ)アクリル酸アル
キルエステル共重合体をブレンドすることにより、粘着
剤成分1本来の優れた特性、すなわち皮膚への無刺激性
と良好な導電性を保有したまま、耐湿性及び内部凝集力
が高められることを発見し、本発明に到達した。
That is, the adhesive (Adhesive I) consisting of vinylpyrrolidone (co)polymer, electrolyte, and softener does not irritate the skin and has good conductivity, but has poor moisture resistance.
The internal cohesive force is weak, which causes problems when attaching and detaching, and is not preferred as a medical conductive adhesive. This adhesive component I
By blending (meth)acrylic acid (salt) with (meth)acrylic acid alkyl ester copolymer, it retains the original excellent properties of adhesive component 1, namely non-irritation to the skin and good electrical conductivity. It was discovered that the moisture resistance and internal cohesive force can be improved while maintaining the temperature, and the present invention has been achieved.

また、上記発明のブレンドポリマーと電解質及び軟化剤
を含む粘着剤に有機カルボン酸(塩)を添加することに
より、さらに耐湿性及び内部凝集力が高められることを
発見し、本発明に到達した。
Furthermore, the inventors have discovered that moisture resistance and internal cohesion can be further enhanced by adding an organic carboxylic acid (salt) to the adhesive containing the blended polymer, electrolyte, and softener of the invention, and have thus arrived at the present invention.

該ビニルビロリドン(共)重合体として、ビニルピロリ
ドンホモボリマー、ビニルピロリドンとアクリル酸、メ
チルメタクリレート、無水マレイン酸、ビニルアルコー
ル等の1種又は2種以上との共重合体が挙げられる。こ
のようなビニルピロリドン(共)重合体は、水及び/も
しくはアルコールに可溶であるものが好ましく用いられ
、また軟化剤を添加することによって、内部凝集力は弱
くとも粘着性は有している必要がある。また、共重合体
中のビニルピロリドン含有率は、粘着剤としての優れた
特性、すなわち皮膚への無刺激性と良好な導電性を保有
するため、及び、(メタ)アクリル酸(塩)−(メタ)
アクリル酸アルキルエステル共重合体をブレンドするこ
とによって耐湿性及び内部凝集力を高めるために70モ
ル%以上好ましくは90モル%以上がよい。
Examples of the vinylpyrrolidone (co)polymer include vinylpyrrolidone homopolymer, and copolymers of vinylpyrrolidone and one or more of acrylic acid, methyl methacrylate, maleic anhydride, vinyl alcohol, and the like. Such a vinylpyrrolidone (co)polymer is preferably used if it is soluble in water and/or alcohol, and by adding a softener, it can be made to have adhesive properties even if its internal cohesive force is weak. There is a need. In addition, the vinylpyrrolidone content in the copolymer is determined to have excellent properties as an adhesive, that is, non-irritant to the skin and good conductivity, and (meth)acrylic acid (salt) -( Meta)
In order to improve moisture resistance and internal cohesive force by blending the acrylic acid alkyl ester copolymer, the amount is preferably 70 mol% or more, preferably 90 mol% or more.

gti(メタ)アクリル酸(塩)−(メタ)アクリル酸
アルキルエステル共重合体は、(メタ)アクリル酸(塩
)と(メタ)アクリル酸アルキルエステルとを共重合し
て得られる。(メタ)アクリル酸(塩)としては、例え
ば、アクリル酸、メタアクリル酸等が挙げられ、(メタ
)アクリル酸アルキルエステルとしては、例えば、(メ
タ)アクリル酸メチル、(メタ)アクリル酸エチル、(
メタ)アクリル酸ブチル、(メタ)アクリル酸−2エチ
ルヘキシル等が挙げられる。
The gti (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer is obtained by copolymerizing (meth)acrylic acid (salt) and (meth)acrylic acid alkyl ester. Examples of (meth)acrylic acid (salt) include acrylic acid, methacrylic acid, etc., and examples of (meth)acrylic acid alkyl ester include methyl (meth)acrylate, ethyl (meth)acrylate, (
Butyl meth)acrylate, 2-ethylhexyl (meth)acrylate, and the like.

該(メタ)アクリル酸(塩)−(メタ)アクリル酸アル
キルエステル共重合体の添加により耐湿性及び内部凝集
力が顕著に高められる理由は詳しくは解らないが、該共
重合体のカルボン酸と、ビニルビロリドン(共)重合体
のピロリドン環とが予想外の相互作用をすることによる
と考えられる。
The reason why moisture resistance and internal cohesive force are significantly increased by the addition of the (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer is not understood in detail, but the reason why the moisture resistance and internal cohesive force are significantly increased by the addition of the (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer is unknown, but the reason is that the carboxylic acid and This is thought to be due to an unexpected interaction between the pyrrolidone ring of the vinylpyrrolidone (co)polymer.

望ましい添加効果を得るためには、ビニルピロリドン(
共)重合体と該重合体が配合液中で相溶している必要が
あり、従って、性状としてpH4以上の水及び/もしく
はアルコールに可溶であることが好ましい.該共重合体
の共重合成分として(メタ)アクリル酸(塩)の含有量
は、5モル%未満であると、粘着剤の耐湿性及び内部′
a集力を高める効果が得られず、90モル%を越えると
配合液がゲル化して均一な溶液が得難いことから、5モ
ル%〜90モル%が好適な範囲であり、更には20モル
%〜80モル%がより好適である.また、該ブレンドポ
リマーにおける該(メタ)アクリル酸(塩)一(メタ)
アクリル酸アルキルエステル共重合体の含有量は、1重
量%未満では耐湿性及び内部凝集力を高める効果が得ら
れず、30重量%をこえるとポリビニルビロリドン(共
)重合体の上記した本来の優れた特性を失うことから、
1重量%〜30重量%の範囲が好適であり、更には5重
量%〜25重量%がより好適である。
To obtain the desired additive effect, vinylpyrrolidone (
The co)polymer and the polymer must be compatible with each other in the compounded liquid, and therefore, it is preferable that the copolymer be soluble in water and/or alcohol with a pH of 4 or more. If the content of (meth)acrylic acid (salt) as a copolymerization component of the copolymer is less than 5 mol%, the moisture resistance and internal
a The effect of increasing concentration cannot be obtained, and if it exceeds 90 mol%, the blended liquid will gel and it will be difficult to obtain a uniform solution, so the preferred range is 5 mol% to 90 mol%, and more preferably 20 mol%. 80 mol% is more preferable. Moreover, the (meth)acrylic acid (salt) mono(meth) in the blend polymer
If the content of the acrylic acid alkyl ester copolymer is less than 1% by weight, the effect of increasing moisture resistance and internal cohesive force will not be obtained, and if it exceeds 30% by weight, the above-mentioned original properties of the polyvinyl pyrrolidone (co)polymer will not be obtained. from losing its excellent properties,
A range of 1% to 30% by weight is preferred, and a range of 5% to 25% by weight is more preferred.

該有機カルボン酸(塩)としては、例えば、酢酸、ステ
アリン酸、フマル酸、マレイン酸、クエン酸、フタル酸
、ポリアクリル酸、およびそれらのナトリウム塩、カリ
ウム塩、カルシウム塩等が挙げられる。該ブレンドポリ
マー100重量部に対する添加量は、O.1重量部〜2
0重量部好ましくは1重量部〜lO重量部であり、O.
1重量部未満では添加効果が発現しにくく、20重量部
をこえると粘着剤中で過飽和状態となり結晶析出等が起
こり易くなる。
Examples of the organic carboxylic acid (salt) include acetic acid, stearic acid, fumaric acid, maleic acid, citric acid, phthalic acid, polyacrylic acid, and their sodium salts, potassium salts, and calcium salts. The amount added to 100 parts by weight of the blend polymer is O. 1 part by weight ~ 2 parts by weight
0 parts by weight, preferably 1 part by weight to 10 parts by weight, O.
If it is less than 1 part by weight, it is difficult to exhibit the effect of addition, and if it exceeds 20 parts by weight, it becomes supersaturated in the adhesive and crystal precipitation etc. tend to occur.

該軟化剤としては、上記ブレンドポリマーを軟化させる
ためのものであるが、同時に電解質を可溶化する性質を
有していればより好ましく、例えば多価アルコール、多
価アルコール誘導体等の高沸点の水溶性または親水性の
液体が好適である。
The softener is used to soften the blended polymer described above, but it is more preferable if it also has the property of solubilizing the electrolyte. Aqueous or hydrophilic liquids are preferred.

具体的には、エチレングリコール、ブロビレングリコー
ル、ジプロピレングリコール、ポリエチレングリコール
、グリセリン等がある。該ブレンドポリマー100重量
部に対する添加量は、20重量部〜500重量部好まし
くは50重量部〜300重量部であり、20重量部未満
では軟化効果が十分ではなく、500重量部をこえると
プリードアウトし易くなる。
Specific examples include ethylene glycol, brobylene glycol, dipropylene glycol, polyethylene glycol, and glycerin. The amount added to 100 parts by weight of the blend polymer is 20 parts by weight to 500 parts by weight, preferably 50 parts by weight to 300 parts by weight. If it is less than 20 parts by weight, the softening effect will not be sufficient, and if it exceeds 500 parts by weight, it will lead out. It becomes easier to do.

該電解質は、他の成分すなわちビニルピロリドン(共)
重合体、(メタ)アクリル酸(塩)一(メタ)アクリル
酸アルキルエステル共重合体、及び軟化剤等は導電性が
低いため、粘着剤に導電性を付与する目的で添加するも
のであり、粘着剤中の移動度が高い方が導電性がよく、
例えばNaCL、K C L, C a C Lx等の
無機塩が好適である.該ブレンドポリマー100重量部
に対する添加量は、0.1重量部〜30重量部好ましく
は1重量部〜20重量部であり、0.l重量部未満では
導電性が発現しにくく、30重量部をこえると粘着剤中
で過飽和状態となり結晶析出等が起こり易くなる。
The electrolyte contains other components, namely vinylpyrrolidone (co-)
Polymers, (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymers, and softeners have low electrical conductivity, so they are added for the purpose of imparting electrical conductivity to the adhesive. The higher the mobility in the adhesive, the better the conductivity.
For example, inorganic salts such as NaCL, KCL, C a C Lx, etc. are suitable. The amount added to 100 parts by weight of the blend polymer is 0.1 parts by weight to 30 parts by weight, preferably 1 part to 20 parts by weight, and 0.1 parts by weight to 30 parts by weight, preferably 1 part to 20 parts by weight. If it is less than 1 part by weight, it is difficult to develop conductivity, and if it exceeds 30 parts by weight, it becomes supersaturated in the adhesive and crystal precipitation etc. tend to occur.

また、本発明の粘着剤には、必要に応じて、薬効成分や
添加剤(例えば、殺菌剤、香料、着色剤等)等が含まれ
ても良い。
Furthermore, the adhesive of the present invention may contain medicinal ingredients, additives (for example, bactericidal agents, fragrances, coloring agents, etc.) as necessary.

(実施例) 本発明を実施例により具体的に説明する。(Example) The present invention will be specifically explained with reference to Examples.

尖旌明よ (A)粘着剤溶液の調製: ビニルピロリドンホモボリマー(BASPS 社製、K
ollidon90) 9 0重量部をメタノール20
0重量部に均一に溶解した(溶液■)。NaCL 1重
量部を日局精製水10重量部に溶解した(溶液■)。
(A) Preparation of adhesive solution: Vinylpyrrolidone homobolymer (manufactured by BASPS, K
ollidon90) 90 parts by weight of methanol 20
It was uniformly dissolved in 0 parts by weight (solution ■). 1 part by weight of NaCL was dissolved in 10 parts by weight of JP purified water (solution ■).

メタアクリル酸一メタアクリル酸メチル共重合体(Ro
hai Pharma製、Euidragit S(メ
タアクリル酸含量25.0〜34.5%)〕10重量部
をメタノール50重量部に溶解した(溶液■)。以上の
溶液■、■、■及びグリセリン(日本油脂製、日局規格
)300重量部を均一に混合して、無色透明な粘着剤溶
液を得た。
Methacrylic acid-methyl methacrylate copolymer (Ro
10 parts by weight of Euidragit S (methacrylic acid content: 25.0-34.5%) manufactured by Hai Pharma was dissolved in 50 parts by weight of methanol (solution ■). The above solutions (1), (2), and (2) and 300 parts by weight of glycerin (manufactured by NOF Corporation, Japan Standards) were uniformly mixed to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作戒及び粘着力の性能評価:(A)
項で得られた粘着剤溶液を厚さ32μmのポリエチレン
テレフタレート(PET)/エチレンービニルアセテー
ト共重合体(EVA)ラミネートフイルム上に、その乾
燥後の厚さが11wII1以上となるように流延し乾燥
させて粘着シートを得た。この粘着シートを4cmX4
cI1の大きさに切断し、皮膚表面に6時間貼付してお
いたが、日常生活の運動により粘着シートが剥がれるこ
とはなかった。このシートを剥がすと、粘着剤層は一時
的に引き伸ばされながら皮膚表面から剥がれた。剥離時
には、適度な粘着力が皮膚に感じられたが、角質層の剥
離及び、皮膚の炎症は認められなかった。また、剥離後
の皮膚表面に粘着剤の一部が残留するという現象も認め
られなかった。
(B) Adhesive sheet etiquette and adhesive strength performance evaluation: (A)
The adhesive solution obtained in Section 1 was cast onto a polyethylene terephthalate (PET)/ethylene-vinyl acetate copolymer (EVA) laminate film with a thickness of 32 μm so that the thickness after drying was 11wII1 or more. It was dried to obtain an adhesive sheet. This adhesive sheet is 4cm x 4
The adhesive sheet was cut to a size cI1 and applied to the skin surface for 6 hours, but the adhesive sheet did not peel off due to daily exercise. When this sheet was peeled off, the adhesive layer was temporarily stretched and peeled off from the skin surface. At the time of peeling, moderate adhesion was felt on the skin, but no peeling of the stratum corneum or inflammation of the skin was observed. Furthermore, no phenomenon was observed in which a portion of the adhesive remained on the skin surface after peeling.

上記粘着シートを2.5cmX5.Ocmに裁断したテ
ープ状のものとなして、日本工業規格「粘着テープ・粘
着シート(z 0237− 191+1) Jに準じて
粘着力代用特性値(保持力)を測定した。その値は、3
0分以上であり、内部凝集力が十分であることを示して
いる。また、粘着シートを1.5cmX20.Ocmに
裁断したテープ状のものとなして、日本工業規格「粘着
テープ・粘着シート(Z 0237一1,,。)」に準
じて粘着力代用特性値(180゜折り返し剥離法)を測
定した。その値は、800g/15mm以上であった。
The above adhesive sheet is 2.5cm x 5. The adhesive force substitute characteristic value (holding force) was measured in accordance with the Japanese Industrial Standards "Adhesive Tape/Adhesive Sheet (z 0237-191+1) J" with a tape cut into 0 cm.The value was 3
0 minutes or more, indicating that the internal cohesive force is sufficient. Also, use an adhesive sheet of 1.5cm x 20cm. The tape was cut into 0 cm pieces, and the adhesive force substitute characteristic value (180° folding and peeling method) was measured in accordance with the Japanese Industrial Standards "Adhesive Tapes and Adhesive Sheets (Z 0237-1, .)". The value was 800g/15mm or more.

(C)粘着剤層の導電性評価: (A)項で得られた粘着剤溶液をシリコーン剥離紙上に
乾燥後の厚さが1mmとなるように流延し、乾燥させた
.この粘着剤層を2cmX2cmに切断し、1 0c+
mX I Oc+aの銅箔(60μm)2枚で両側から
挟みサンドインチ状の試験片を得た。この試験片を用い
2枚の銅箔の間のインピーダンスをIKHz、10ll
lv、接触圧100g/cjの条件下でLCRメーター
により測定したところ、その値は264Ωであった。
(C) Evaluation of electrical conductivity of adhesive layer: The adhesive solution obtained in section (A) was cast onto a silicone release paper to a dry thickness of 1 mm, and dried. Cut this adhesive layer into 2 cm x 2 cm, and
A sandwich-shaped test piece was obtained by sandwiching two sheets of mX I Oc+a copper foil (60 μm) from both sides. Using this test piece, the impedance between two pieces of copper foil was measured at IKHz, 10ll.
When measured using an LCR meter under the conditions of lv and contact pressure of 100 g/cj, the value was 264 Ω.

裏胤斑主 (A)粘着剤溶液の調製: ビニルビロリドンホモボリマー(BASFS 社m、K
ollidon90) 9 0重量部をメタノール20
0重量部に均一に溶解した(溶液I)。クエン酸3Na
2重量部、NaCL 1重量部を日局精製水10重量部
に溶解した(溶液■).メタアクリル酸一メタアクリル
酸メチル共重合体(Robn+ Phar+sa製、E
uidragit S(メタアクリル酸含量25.0 
〜34.5%)〕 10重量部をメタノール50重量部
に溶解した(溶液I[1).以上の溶液I、■、■及び
グリセリン(日本油脂製、日周規格)300重量部を均
一に混合して、無色透明な粘着剤溶液を得た。
Preparation of adhesive solution (A): Vinyl pyrrolidone homopolymer (BASFS M, K
ollidon90) 90 parts by weight of methanol 20
It was uniformly dissolved in 0 parts by weight (Solution I). trisodium citric acid
2 parts by weight and 1 part by weight of NaCL were dissolved in 10 parts by weight of JP purified water (solution ■). Methacrylic acid-methyl methacrylate copolymer (Robn+ Phar+sa, E
uidragit S (methacrylic acid content 25.0
~34.5%)] was dissolved in 50 parts by weight of methanol (Solution I [1). The above solutions I, ①, ② and 300 parts by weight of glycerin (manufactured by NOF Corporation, diurnal standard) were uniformly mixed to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作戒及び粘着力の性能評価二本実施
例(A)項で得られた粘着剤溶液を実施例1(B)項と
同様の方法で粘着シートを作或し、粘着力の評価を行っ
た.その結果は、実施例1(B)項と同様であった。但
し、粘着力代用特性値(保持力)は50分以上であり、
粘着力代用特性値(180’折り返し剥離法)は、8 
0 0 g/15DIII+以上であった。
(B) Performance evaluation of tackiness and adhesion of the PSA sheet 2. The adhesive solution obtained in Example 1 (A) was used to prepare an PSA sheet in the same manner as in Example 1 (B). We evaluated the power. The results were similar to those in Example 1 (B). However, the adhesive force substitute characteristic value (holding force) is 50 minutes or more,
Adhesive force substitute characteristic value (180' folding peeling method) is 8
It was 0 0 g/15DIII+ or more.

(C)粘着剤層の導電性評価; 本実施例(A)項で得られた粘着剤溶液を用い実施例1
 (C)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer; Example 1 using the adhesive solution obtained in section (A) of this example
Impedance was measured in the same manner as in section (C).

試験片のインピーダンスは、237Ωであった。The impedance of the test piece was 237Ω.

夫嵐汎主 (A)粘着剤溶液の調製: メタアクリル酸含量を表1の比率で変えてメタアクリル
酸一メタアクリル酸メチル共重合体を作威し、それぞれ
の共重合体を用いた以外は実施例1と同様にして9種類
の粘着剤溶液を調製した。
Preparation of adhesive solution by Huarashi Hanji (A): A methacrylic acid-methyl methacrylate copolymer was prepared by changing the methacrylic acid content in the ratio shown in Table 1, and each copolymer was used. Nine types of adhesive solutions were prepared in the same manner as in Example 1.

(B)粘着シートの作成及び粘着力の性能評価:本実施
例(A)項で得られたそれぞれの粘着剤溶液を用い、実
施例1(B)項と同様の方法で粘着シートを作或し、粘
着力(保持力)の評価を行った。その結果を表1に示す
(B) Preparation of adhesive sheets and performance evaluation of adhesive strength: Using each adhesive solution obtained in Section (A) of this Example, adhesive sheets were prepared in the same manner as in Section (B) of Example 1. Then, the adhesive force (holding force) was evaluated. The results are shown in Table 1.

(以下余白) 以上のことから、内部凝集力があり均一な溶液が得られ
る(メタ)アクリル酸−(メタ)アクリル酸エステル共
重合体の(メタ)アクリル酸含量は、5モル%〜90%
が好適な範囲であり、更には20モル%〜80モル%が
より好適である。
(Left below) From the above, the (meth)acrylic acid content of the (meth)acrylic acid-(meth)acrylic acid ester copolymer that has internal cohesive force and provides a uniform solution is 5 mol% to 90%.
The preferred range is 20 mol% to 80 mol%.

夫益班工 (A)粘着剤溶液の調製二 メタアクリル酸−メタアクリル酸メチル共重合体量を表
2の割合で配合して得たブレンドポリマーを用いた以外
は、実施例1と同様にして粘着剤溶液を調製した。
Fumasu Group (A) Preparation of adhesive solution The procedure was repeated in the same manner as in Example 1, except that a blend polymer obtained by blending the amount of dimethacrylic acid-methyl methacrylate copolymer in the ratio shown in Table 2 was used. An adhesive solution was prepared.

(B)粘着シートの作戒及び粘着力の性能評価二本実施
例(A)項で得られたそれぞれの粘着剤溶液を用い、実
施例1 (B)項と同様の方法で粘着シートを作成し、
皮膚に対する貼付性及び粘着力(保持力)の評価を行っ
た。その結果を表2に示す。
(B) Performance evaluation of tackiness and adhesion of adhesive sheets 2 Using each of the adhesive solutions obtained in Example 1 (A), adhesive sheets were prepared in the same manner as in Example 1 (B). death,
The adhesion to the skin and adhesive strength (holding strength) were evaluated. The results are shown in Table 2.

(以下余白) 以上のことから、内部凝集力がありかつビニルピロリド
ン(共)重合体の本来の優れた特性を保つ、ブレンドポ
リマーにおける(メタ)アクリル酸−(メタ)アクリル
酸エステル共重合体量は、1重量%〜30重量%が好適
な範囲であり、更には5重量%〜25重量%がより好適
である。
(Left below) From the above, the amount of (meth)acrylic acid-(meth)acrylic acid ester copolymer in the blend polymer that has internal cohesive force and maintains the original excellent properties of vinylpyrrolidone (co)polymer. The range is preferably from 1% by weight to 30% by weight, and more preferably from 5% by weight to 25% by weight.

夫益盟工 (A)粘着剤溶液の調製; ビニルピロリドンホモボリマー(BASF社製、Ko1
1idon 90 )  7 5重量部をメタノール2
00重量部に均一に溶解した(溶液{)。Na CL 
1重量部を日局精製水IO重量部に溶解した(溶液■)
.メタアクリル酸一メタアクリル酸メチル共重合体(R
ohm Pharma製、Euidragit LIO
O−55(メタアクリル酸含量38〜52%)〕25重
量部をメタノール50重量部に溶解した(熔液■)。以
上の溶冫&I、■、■及びポリエチレングリコーノレ6
00(日本油脂製、日局外規格)250重量部を均一に
混合して、無色透明な粘着剤溶液を得た。
Preparation of adhesive solution (A); Vinylpyrrolidone homobolymer (manufactured by BASF, Ko1
1idon 90) 7 5 parts by weight of methanol 2
00 parts by weight (solution {). Na CL
1 part by weight was dissolved in IO parts by weight of JP purified water (solution ■)
.. Methacrylic acid-methyl methacrylate copolymer (R
Eudragit LIO manufactured by ohm Pharma
25 parts by weight of O-55 (methacrylic acid content: 38-52%) was dissolved in 50 parts by weight of methanol (solution ■). The above melt & I, ■, ■ and polyethylene glycol 6
250 parts by weight of 00 (manufactured by Nippon Oil & Fats Co., Ltd., Japan External Standards) were mixed uniformly to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作戒及び粘着力の性能評価:本実施
例(A)項で得られた粘着剤溶液を実施例1 (B)項
と同様の方法で粘着シートを作威し、粘着力の評価を行
った。その結果は、実施例1(B)項と同様であった。
(B) Performance evaluation of adhesive sheet discipline and adhesive strength: The adhesive solution obtained in section (A) of this example was used to prepare an adhesive sheet in the same manner as in Example 1 (B). We evaluated the power. The results were similar to those in Example 1 (B).

但し、粘着力代用特性値(保持力)は30分以上であり
、粘着力代用特性値(l80゜折り返し剥離法)は、7
 0 0 g/15m++以上であった。
However, the adhesive force substitute characteristic value (holding force) is 30 minutes or more, and the adhesive force substitute characteristic value (l80° folding peeling method) is 7.
0 0 g/15m++ or more.

(C)粘着剤層の導電性評価: 本実施例(A)項で得られた粘着剤溶液を用い実施例1
 (C)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer: Example 1 using the adhesive solution obtained in section (A) of this example.
Impedance was measured in the same manner as in section (C).

試験片のインピーダンスは、269Ωであった。The impedance of the test piece was 269Ω.

夫脂旌i (A)粘着剤溶液の調製: ビニルビロリドンホモボリマ−(BASP社製、Ko1
1idon 90 )  7 5重量部をメタノール2
00重量部に均一に溶解した(溶液■)。マレイン酸2
Na2重量部、NaCL 1重量部を日局精製水10重
量部に溶解した(溶液■)。メタアクリル酸一アクリル
酸エチル共重合体(Rohm Pharma製、Eui
dragit L100−55(メタアクリル酸含量3
8〜52%)〕25重量部をメタノール50重量部に溶
解した(溶液■)。以上の溶液■、■、■及びポリエチ
レングリコール600(日本油脂製、日局外規格)25
0重量部を均一に混合して、無色透明な粘着剤溶液を得
た。
(A) Preparation of adhesive solution: Vinyl pyrrolidone homobolymer (manufactured by BASP, Ko1
1idon 90) 7 5 parts by weight of methanol 2
00 parts by weight (solution ■). maleic acid 2
2 parts by weight of Na and 1 part by weight of NaCL were dissolved in 10 parts by weight of JP purified water (solution ■). Methacrylic acid monoethyl acrylate copolymer (manufactured by Rohm Pharma, Eui
dragit L100-55 (methacrylic acid content 3
8-52%)] was dissolved in 50 parts by weight of methanol (Solution ■). The above solutions ■, ■, ■ and polyethylene glycol 600 (manufactured by Nippon Oil & Fats Co., Ltd., Japanese non-prescription standard) 25
0 parts by weight were mixed uniformly to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作戒及び粘着力の性能評価:本実施
例(A)項で得られた粘着剤溶液を実施例1 (B)項
と同様の方法で粘着シートを作成し、粘着力の評価を行
った。その結果は、実施例I(B)項と同様であった。
(B) Performance evaluation of adhesive sheet discipline and adhesive strength: An adhesive sheet was prepared using the adhesive solution obtained in section (A) of this example in the same manner as in Example 1 (B), and the adhesive strength was evaluated. The results were similar to Example I(B).

但し、粘着力代用特性値(保持力)は50分以上であり
、粘着力代用特性値(180゜折り返し剥離法)は、7
 0 0 g/15mm以上であった。
However, the adhesive force substitute characteristic value (holding force) is 50 minutes or more, and the adhesive force substitute characteristic value (180° folding and peeling method) is 7.
It was 0.0 g/15 mm or more.

(C)粘着剤層の導電性評価: 本実施例(A)項で得られた粘着剤溶液を用い実施例1
 (C)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer: Example 1 using the adhesive solution obtained in section (A) of this example.
Impedance was measured in the same manner as in section (C).

試験片のインピーダンスは、312Ωであった。The impedance of the test piece was 312Ω.

夫胤班ユ (A)粘着剤溶液の調製: ビニルピロリドンホモポリマー(BASF社製、Ko1
1idon 90 )  9 5重量部をメタノール2
00重量部に均一に溶解した(溶液I)。NaCL1重
量部を日局精製水10重量部に溶解した(溶液■)。
Preparation of adhesive solution (A): Vinylpyrrolidone homopolymer (manufactured by BASF, Ko1
1idon 90) 9 5 parts by weight with 2 parts of methanol
00 parts by weight (solution I). 1 part by weight of NaCL was dissolved in 10 parts by weight of Japanese Pharmacopoeia purified water (solution ■).

メタアクリル酸一メタアクリル酸メチル共重合体(Ro
hm Pharma製、Euidragit LIOO
 (メタアクリル酸含it38.0〜52.0%)〕5
重量部をメタノール20重量部に溶解した(溶液■)。
Methacrylic acid-methyl methacrylate copolymer (Ro
Made by hm Pharma, Euidragit LIOO
(Methacrylic acid content: 38.0-52.0%)]5
Part by weight was dissolved in 20 parts by weight of methanol (solution ■).

以上の溶液■、■、■及びグリセリン(日本油脂製、日
局規格)250重量部を均一に混合して、無色透明な粘
着剤溶液を得た。
The above solutions (1), (2), and (2) and 250 parts by weight of glycerin (manufactured by NOF Corporation, Japan Standards) were uniformly mixed to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作或及び粘着力の性能評価二本実施
例(A)項で得られた粘着剤溶液を実施例1 (B)項
と同様の方法で粘着シートを作戒し、粘着力の評価を行
った。その結果は、実施例1(B)項と同様であった。
(B) Preparation of pressure-sensitive adhesive sheet and performance evaluation of adhesive strength (2) The pressure-sensitive adhesive solution obtained in Example 1 (A) was prepared into a pressure-sensitive adhesive sheet in the same manner as in Example 1 (B). We evaluated the power. The results were similar to those in Example 1 (B).

但し、粘着力代用特性値(保持力)は30分以上であり
、粘着力代用特性値(180”折り返し剥離法)は、8
91g/15開以上であった。
However, the adhesive force substitute characteristic value (holding force) is 30 minutes or more, and the adhesive force substitute characteristic value (180" folding and peeling method) is 8.
It was 91g/15 or more.

(C)粘着剤層の導電性評価: 本実施例(A)項で得られた粘着剤溶液を用い実施例1
 (C)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer: Example 1 using the adhesive solution obtained in section (A) of this example.
Impedance was measured in the same manner as in section (C).

試験片のインピーダンスは、228Ωであった。The impedance of the test piece was 228Ω.

実104集 (A)粘着剤溶液の調製: ビニルビロリドンーメチルメタクリレート共重合体(モ
ル比:95:5)を作戒し、この共重合体95重量部を
メタノール200重量部に均一に溶解した(溶液I)。
Example 104 (A) Preparation of adhesive solution: Prepare vinylpyrrolidone-methyl methacrylate copolymer (molar ratio: 95:5) and uniformly dissolve 95 parts by weight of this copolymer in 200 parts by weight of methanol. (Solution I).

KCLIO重量部及び酢酸・Na  5重量部を日局精
製水50重量部に溶解した(溶液■)。アクリル酸一ア
クリル酸−2−エチルヘキシル共重合体(アクリル酸含
量70%)を作戊し、この共重合体5重量部をメタノー
ル50重量部に溶解した(溶液■)。以上の溶液■、■
、■及びポリエチレングリコール600(和光純薬社製
、特級)100重量部を均一に混合して、無色透明な粘
着剤溶液を得た。
Parts by weight of KCLIO and 5 parts by weight of acetic acid/Na were dissolved in 50 parts by weight of JP purified water (solution ■). A monoacrylic acid-2-ethylhexyl acrylate copolymer (acrylic acid content: 70%) was prepared, and 5 parts by weight of this copolymer was dissolved in 50 parts by weight of methanol (solution 2). The above solutions■,■
, (2) and 100 parts by weight of polyethylene glycol 600 (manufactured by Wako Pure Chemical Industries, Ltd., special grade) were uniformly mixed to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作戒及び粘着力の性能評価:本実施
例(A)項で得られた粘着剤溶液を実施例1 (B)項
と同様の方法で粘着シートを作戒し、粘着力の評価を行
った。その結果は、実施例l(B)項と同様であった。
(B) Performance evaluation of adhesive strength and adhesion of adhesive sheet: The adhesive solution obtained in section (A) of this example was applied to an adhesive sheet in the same manner as in section (B) of Example 1. We evaluated the power. The results were similar to those in Example 1(B).

但し、粘着力代用特性値(保持力)は20分以上であり
、粘着力代用特性値(180゜折り返し剥離法)は、5
 0 0 g/15mm以上であった。
However, the adhesive force substitute characteristic value (holding force) is 20 minutes or more, and the adhesive force substitute characteristic value (180° folding and peeling method) is 5 minutes.
It was 0.0 g/15 mm or more.

(C)粘着剤層の導電性評価: 本実施例(A)項で得られた粘着剤溶液を用い実施例1
 (C)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer: Example 1 using the adhesive solution obtained in section (A) of this example.
Impedance was measured in the same manner as in section (C).

試験片のインピーダンスは、348Ωであった。The impedance of the test piece was 348Ω.

実104i (A)粘着剤溶液の調製: ビニルピロリドンーアクリル酸共重合体(モノレ比:9
0:10)を作戒し、この共重合体80重量部をメタノ
ール200重量部に均一に溶解した(溶液I)。KCL
5重量部を日局精製水50重量部に溶解した(溶液■)
。アクリル酸一アクリル酸ブチル共重合体(アクリル酸
含N30%)を作威し、この共重合体20重量部をメタ
ノール50重量部に溶解した(溶液■)。以上の溶液I
、■、■及びポリエチレングリコール600(和光純薬
社製、特級)200重量部を均一に混合して、無色透明
な粘着剤溶液を得た。
Fruit 104i (A) Preparation of adhesive solution: Vinylpyrrolidone-acrylic acid copolymer (monoole ratio: 9
0:10), and 80 parts by weight of this copolymer was uniformly dissolved in 200 parts by weight of methanol (solution I). K.C.L.
5 parts by weight was dissolved in 50 parts by weight of JP purified water (solution ■)
. A copolymer of acrylic acid and butyl acrylate (acrylic acid content: 30% N) was prepared, and 20 parts by weight of this copolymer was dissolved in 50 parts by weight of methanol (solution 2). Solution I above
, ■, ■ and 200 parts by weight of polyethylene glycol 600 (manufactured by Wako Pure Chemical Industries, Ltd., special grade) were uniformly mixed to obtain a colorless and transparent adhesive solution.

(B)粘着シートの作成及び粘着力の性能評価二本実施
例(A)項で得られた粘着剤溶液を実施例1 (B)項
と同様の方法で粘着シートを作戒し、粘着力の評価を行
った。その結果は、実施例l(B)項と同様であった.
但し、粘着力代用特性値(保持力)は40分以上であり
、粘着力代用特性値(180゜折り返し剥離法)は、7
 5 0 g/15mm以上であった。
(B) Preparation of adhesive sheet and performance evaluation of adhesive force (2) The adhesive solution obtained in Example 1 (A) was prepared into an adhesive sheet in the same manner as in Example 1 (B), and the adhesive strength was evaluated. The results were similar to those in Example 1(B).
However, the adhesive force substitute characteristic value (holding force) is 40 minutes or more, and the adhesive force substitute characteristic value (180° folding and peeling method) is 7.
It was 50 g/15 mm or more.

(C)粘着剤層の導電性評価: 本実施例(A)項で得られた粘着剤溶液を用い実施例1
(C’)項と同様の方法でインピーダンスを測定した。
(C) Conductivity evaluation of adhesive layer: Example 1 using the adhesive solution obtained in section (A) of this example.
Impedance was measured in the same manner as in section (C').

試験片のインピーダンスは、306Ωであった。The impedance of the test piece was 306Ω.

(発明の効果) 本発明によれば、このように優れた導電性と粘着性とを
有する導電性粘着剤が得られる。この導電性粘着剤を用
いた皮膚電極は、皮膚表面へ簡単に貼付され得、固定用
の補助手段を必要としない。
(Effects of the Invention) According to the present invention, a conductive adhesive having such excellent conductivity and adhesiveness can be obtained. Skin electrodes using this conductive adhesive can be easily applied to the skin surface and do not require any auxiliary means for fixation.

この導電性粘着剤は、水を含有させる必要がないため、
電極の使用中あるいは保存中に水の蒸発による導電性及
び粘着性の変化がなく、従って電気的な性能に影響を与
えることがない。また、水の蒸発を防止するための特殊
な包装を必要とじなし)ため、導電性粘着剤を安価に提
供し得る。さらに、金属粉末などを含有しないため、電
気的なノイズの混入も殆ど認めちれない。また、粘着剤
が天然の高分子材料を含んでいないため保存中などに微
生物が繁殖することなく、それらによる異臭や皮膚刺激
も起こらない。本導電性粘着剤ボリマーの主構戒モノマ
ーは、そのホモボリマーが日本薬局方収載品でもあるビ
ニルピロリドンであることから、生体に対する安全性は
高い。
This conductive adhesive does not need to contain water, so
There is no change in conductivity or adhesion due to water evaporation during use or storage of the electrode, and thus electrical performance is not affected. Furthermore, since there is no need for special packaging to prevent water evaporation), the conductive adhesive can be provided at low cost. Furthermore, since it does not contain metal powder or the like, electrical noise is hardly detected. In addition, since the adhesive does not contain natural polymeric materials, microorganisms do not grow during storage, and they do not cause unpleasant odors or skin irritation. The main structural monomer of the present conductive adhesive polymer is vinylpyrrolidone, which is a homopolymer listed in the Japanese Pharmacopoeia, so it is highly safe for living organisms.

特に、共重合体の共重合成分として(メタ)アクリル酸
(塩)を5モル%〜90モル%含有させ、共重合体をブ
レンドポリマー中にl重量%〜30重量%含有させるこ
とにより、更には、粘着剤中に有機カルボン酸(塩)を
含有させることにより、導電性粘着剤の内部凝集力を大
きくすることでき、厚膜の粘着剤層を形成することがで
きると共に凝集力を上げるための不織布等の補強材を特
に必要としない。また、いわゆる糊割れ現象や糊残り現
象が発生しない。このような導電性粘着剤は、各種医療
用機器に簡単かつ有用に利用され得る。
In particular, by containing 5 mol % to 90 mol % of (meth)acrylic acid (salt) as a copolymerization component of the copolymer and 1 wt % to 30 wt % of the copolymer in the blend polymer, By incorporating an organic carboxylic acid (salt) into the adhesive, the internal cohesive force of the conductive adhesive can be increased, making it possible to form a thick adhesive layer and increasing the cohesive force. There is no particular need for reinforcing materials such as non-woven fabric. Moreover, so-called adhesive cracking phenomenon and adhesive remaining phenomenon do not occur. Such a conductive adhesive can be easily and usefully used in various medical devices.

Claims (1)

【特許請求の範囲】 1、ビニルピロリドン(共)重合体と(メタ)アクリル
酸(塩)−(メタ)アクリル酸アルキルエステル共重合
体のブレンドポリマーと、電解質及び軟化剤を含有する
医療用導電性粘着剤。 2、ビニルピロリドン(共)重合体と(メタ)アクリル
酸(塩)−(メタ)アクリル酸アルキルエステル共重合
体のブレンドポリマーと、電解質及び軟化剤を含有する
医療用導電性粘着剤であって、 該(メタ)アクリル酸(塩)−(メタ)アクリル酸アル
キルエステル共重合体には(メタ)アクリル酸(塩)が
共重合体成分として5モル%〜90モル%含有され、該
(メタ)アクリル酸(塩)−(メタ)アクリル酸アルキ
ルエステル共重合体が該ブレンドポリマー中に1重量%
〜30重量%含有されている医療用導電性粘着剤。 3、ビニルピロリドン(共)重合体と(メタ)アクリル
酸(塩)−(メタ)アクリル酸アルキルエステル共重合
体のブレンドポリマーと、電解質、軟化剤及び有機カル
ボン酸を含有する医療用導電性粘着剤。
[Scope of Claims] 1. Medical conductive material containing a blend polymer of vinylpyrrolidone (co)polymer and (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer, an electrolyte and a softener. adhesive. 2. A medical conductive adhesive containing a blend polymer of vinylpyrrolidone (co)polymer and (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer, an electrolyte, and a softener. The (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer contains 5 mol% to 90 mol% of (meth)acrylic acid (salt) as a copolymer component; ) Acrylic acid (salt) - (meth)acrylic acid alkyl ester copolymer is 1% by weight in the blend polymer.
Medical conductive adhesive containing ~30% by weight. 3. Medical conductive adhesive containing a blend polymer of vinylpyrrolidone (co)polymer and (meth)acrylic acid (salt)-(meth)acrylic acid alkyl ester copolymer, electrolyte, softener, and organic carboxylic acid agent.
JP2220450A 1989-08-22 1990-08-21 Medical conductive adhesive Expired - Fee Related JPH0783743B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2220450A JPH0783743B2 (en) 1989-08-22 1990-08-21 Medical conductive adhesive

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP21701989 1989-08-22
JP1-217019 1989-08-22
JP21701889 1989-08-22
JP1-217018 1989-08-22
JP2220450A JPH0783743B2 (en) 1989-08-22 1990-08-21 Medical conductive adhesive

Publications (2)

Publication Number Publication Date
JPH03162829A true JPH03162829A (en) 1991-07-12
JPH0783743B2 JPH0783743B2 (en) 1995-09-13

Family

ID=27329964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2220450A Expired - Fee Related JPH0783743B2 (en) 1989-08-22 1990-08-21 Medical conductive adhesive

Country Status (1)

Country Link
JP (1) JPH0783743B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520180A (en) * 1991-11-15 1996-05-28 Minnesota Mining And Manufactoring Company Biomedical electrodes containing solid state conductive polymer compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749431A (en) * 1980-09-08 1982-03-23 Tokyo Eizai Lab Gel like compound for live body electrode
JPS62321A (en) * 1985-06-24 1987-01-06 積水化学工業株式会社 Medical conductive adhesive and medical adhesive electrode using the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5749431A (en) * 1980-09-08 1982-03-23 Tokyo Eizai Lab Gel like compound for live body electrode
JPS62321A (en) * 1985-06-24 1987-01-06 積水化学工業株式会社 Medical conductive adhesive and medical adhesive electrode using the same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520180A (en) * 1991-11-15 1996-05-28 Minnesota Mining And Manufactoring Company Biomedical electrodes containing solid state conductive polymer compositions
US5536446A (en) * 1991-11-15 1996-07-16 Minnesota Mining And Manufacturing Company Solid state conductive polymer compositions

Also Published As

Publication number Publication date
JPH0783743B2 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
TWI306887B (en)
US4990339A (en) Dermal treatment film
JP3457308B2 (en) Biomedical electrodes with two-phase composite conductive pressure-sensitive adhesive
AU657188B2 (en) Pressure-sensitive poly(N-vinyl lactam) adhesive composition and method for producing and using same
US4947847A (en) Electrically conductive adhesive
HUT53925A (en) Water-soluble, pressure-senzible leather-adhesive, it's application and composition containing them
EP1253913B1 (en) Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
NO177663B (en) Method of Preparation of Pharmaceutical Preparation with Nitroglycerin for Percutaneous Administration
JPH0228978B2 (en)
JP2002356661A (en) Pressure sensitive-adhesive composition, method for manufacturing the same, and bioelectric electrodes using the same
JPH03162829A (en) Conductive tacky adhesive agent for medical treatment
JPH0456621B2 (en)
CN112826809A (en) Stable tulobuterol percutaneous absorption preparation
JPH05320612A (en) Self-adhesive composition
JPH04266742A (en) Medical conducting adhesive
JPS62321A (en) Medical conductive adhesive and medical adhesive electrode using the same
JP3554573B2 (en) Aspirin-containing transdermal preparation
US20060149183A1 (en) Moisture-activatable adhesives for medical application purposes
JPH1095962A (en) Electroconductive adhesive composition, electroconductive pad obtained from the same composition and medical electrode using the same
JP2005304756A (en) Skin-stickable adhesive sheet
JPS63112673A (en) Hydrophilic tacky composition
JPH06346041A (en) Hydrophilic tacky agent composition
JPH0816213B2 (en) Hydrophilic adhesive composition
JPH058020B2 (en)
JP2004313710A (en) Pressure-sensitive adhesive for skin protection, pressure-sensitive adhesive composition for skin protection, and pressure-sensitive adhesive sheet for skin protection

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees